Neurogene Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $20.4M | $163.3M | $142.5M |
| FY2022 | $10.6M | $109.3M | $82.0M |
| FY2023 | $36.5M | $222.6M | $148.2M |
| FY2024 | $25.4M | $335.7M | $136.6M |
| FY2025 | $23.7M | $288.6M | $103.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $20.4M | $163.3M | $142.5M |
| FY2022 | $10.6M | $109.3M | $82.0M |
| FY2023 | $36.5M | $222.6M | $148.2M |
| FY2024 | $25.4M | $335.7M | $136.6M |
| FY2025 | $23.7M | $288.6M | $103.8M |